Biologics Facilities Expand and Establish New Locations in 2021
The latest news about biologics facilities includes various expansions, new locations, and acquisitions in the bio/pharmaceutical space.
Biologics facilities have expanded and advanced within the past few months in terms of significant investments, construction on new facilities, and acquisitions of new locations. The following are a sampling of these advances.
Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing May 2021 eBook.
About the Author
Lauren Lavelle is assistant editor of Pharmaceutical Technology.
Article Details
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2021
May 2021
Pages: 60–62
Citation
When referring to this article, please cite it as L. Lavelle, “Biologics Facilities Expand and Establish New Locations in 2021," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
